SCHEMBL21045877

SCHEMBL21045877

CC(C)(C)N(C(=O)O)c1ccccc1CON1C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HTT P42858 1/20 0.47
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 1/20 0.44
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 3/20 0.39
ATM Q13315 1/20 0.37
RECQL P46063 1/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21046003 0.77 IDO1 (0.42) HTTMEN1KMT2A
SCHEMBL1208112 0.73 MEN1 (0.37) ALDH1A1HTTCYP2C9MEN1KMT2A
SCHEMBL20564934 0.72 KMT2A (0.36) ALDH1A1HTTCYP2C9MEN1KMT2A
SCHEMBL1209124 0.72 MEN1 (0.36) ALDH1A1HTTCYP2C9MEN1KMT2A
SCHEMBL16714956 0.71 MEN1 (0.50) ALDH1A1HTTCYP1A2CYP2C9MEN1
SCHEMBL1974011 0.70 KMT2A (0.38) ALDH1A1HTTCYP2C9MEN1KMT2A
SCHEMBL6130286 0.69 ALDH1A1 (0.52) ALDH1A1HTTCYP1A2CYP2C9MEN1
SCHEMBL11001273 0.69 ALDH1A1 (0.52) ALDH1A1HTTCYP1A2CYP2C9MEN1
SCHEMBL4281258 0.69 GAA (0.48) ALDH1A1CYP1A2CYP2C9MEN1KMT2A
SCHEMBL1619883 0.69 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same ARBUTUS BIOPHARMA CORPORATION (CA) 2020-02-04 US disclosed
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same RNASEH1, RNASE1, RNASEL ALDH1A1 1249/4885HTT 2050/4885CYP1A2 629/4885
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME RNASEH1, RNASE1, RNASEL ALDH1A1 1249/4885HTT 2050/4885CYP1A2 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.